Effect of chronic treatment with losartan on streptozotocin-induced renal dysfunction

Molecular and Cellular Biochemistry

Volumn 249, Issue 1-2, 2003, Pages 85-90

  Murali, B ^a   Umrani, Dhananjay N ^a   Goyal, Ramesh K ^a  

^a L M COLLEGE OF PHARMACY   (India)

Author keywords

Losartan; Renal dysfunction; Streptozotocin diabetes

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CREATININE; ELECTROLYTE; LOSARTAN; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; CHEMICAL PARAMETERS; COMORBIDITY; CONTROLLED STUDY; CORRELATION FUNCTION; CREATININE CLEARANCE; DATA ANALYSIS; DIABETES MELLITUS; FEMALE; HISTOPATHOLOGY; HYPERGLYCEMIA; HYPERTENSION; HYPOINSULINEMIA; KIDNEY DYSFUNCTION; KIDNEY HYPERTROPHY; LONG TERM CARE; MEDICAL DECISION MAKING; NONHUMAN; RAT; SYMPTOMATOLOGY; WEIGHT REDUCTION;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CREATININE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; FEMALE; HYPERGLYCEMIA; HYPERTENSION, RENAL; KIDNEY; LOSARTAN; RATS; RATS, WISTAR; STREPTOZOCIN;

ANIMALIA;

EID: 0041974949     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024707326943     Document Type: Article

References (36)

1. Borch-Johnsen K, Andersen PK, Deckert T: The effect of proteinuria on relative mortality in type I (insulin-dependent diabetes mellitus. Diabetologia 28: 590-596, 1985
2. Vora JP, David J, David W, Peterson RO: Renal hemodynamics in newly presenting non-insulin dependent diabetes mellitus. Kidney Int 41: 829-835, 1992
3. Rettig B, Teusch SM: The incidence of end stage renal failure in type I and type II diabetes mellitus. Diabetic Nephrol 3: 26-27, 1992
4. Flemming SN, Peter R, Mari AG, Peter S, Ulla MS, Parving HH: Impact of Lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy. Diabetes 43: 1108-1113, 1994
5. Michel M: Diabetic nephropathy: The ACE hypothesis. J Dia Comp 10: 126-128, 1996
6. Friberg P, Sundelin B, Bohman SO, Bobik A, Nilsson H, Wickman A, Gustafsson H, Peterson J, Adams MA: Renin-angiotensin system in neonatal rats: Induction of renal abnormality in response to ACE inhibition or angiotensin II antagonism. Kidney Int 45: 485-492, 1994
7. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM: Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77: 1925-1930, 1986
8. Goyal RK, Lakkad NB, Rao MV: Effects of chronic treatment with enalapril on streptozotocin induced diabetic rats. Pharmacol Rev Comm 5: 201-209, 1997
9. Cheng IKP, Ma JTC, Yeh GR, Chan MK: Comparison of captopril and enalapril in the treatment of hypertension in patients with non-insulin dependent diabetes mellitus and nephropathy. Int Urol Nephrol 22: 295-303, 1990
10. Hommel E, Parving HH, Mathiesen E, Edsberg B, Nielson MD, Giese J: Effect of capropril on kidney function in insulin dependent diabetic patients with nephropathy. Br Med J 293: 467-470, 1986
11. Mogensen CE, Christensen CK: Predicting diabetic nephropathy in insulin dependent patients. N Eng J Med 311: 89-93, 1984
12. Anderson S, Rannke HG, Garcia DL, Brenner BM: Short and long term effects of antihypertensive therapy in diabetic rat. Kidney Int 36: 526-536, 1989
13. Lowry OH, Rosebrough NJ, Farr AI, Randall RJ: Protein measurement with folin phenol reagent. J Biol Chem 193: 265-275, 1951
14. Sevak AR, Goyal RK: Effects of chronic treatment with lisinopril on cardiovascular complications in streptozotocin-induced diabetic and DOCA hypertensive rats. Pharm Res 34: 201-209, 1996
15. Kawashima H: Chronic hypertension induced by STZ in rats. Naunyn Schiemedberg Arch Pharmacol 305: 123-126, 1978
16. Rodrigues B, Goyal RK, McNeill JH: Effects of hydralazine on STZ-induced diabetic rats - prevention of hyperlipidaemia and improvement in cardiac function. J Pharmacol Exp Ther 237: 292-299, 1986
17. Ritz E, Hasslacher C, Guo J-Z, Mann JFE: Role of hypertension in diabetic nephropathy. In: A. Heidland, K.M. Koch, E. Heidbrder (ed). Diabetes and the Kidney. Basal Krager, 1989, pp 91-101
18. Mogensen CE, Christensen CK: Blood pressure changes and renal function in incipient and over diabetic nephropathy. Hypertension 7: 1164-1173, 1985
19. McCance RA, Widdowson EM: Functional disorganization of the kidney in disease. J Physiol 95: 36-44, 1939
20. Dunn B R, Zatz R: Prevention of glomerular capillary hypertension in experimental diabetes mellitus obviates functional and structural glomerular injury. J Hypertens 4: S251-S254, 1986
21. Valvo E, Bedogna V, Casagrande P: Captopril in patients with type II diabetes and renal insufficiency: Systemic and renal hemodynamic alterations. Am J Med 85: 344-348, 1988
22. Bjorck S, Mulec H, Johnsen SA: Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy. Br Med J 300: 904-907, 1990
23. Hricik DE, Browning PJ, Kopelman R, Goorno WE, Madias NE, Dzau VJ: Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenosis or renal-artery stenosis in a solitary kidney. N Eng J Med 308: 373-375, 1983
24. Taguma Y, Katamote Y, Futaki G, Veda H, Nonma H, Bhizaki M, Takakashi H, Seiko H, Sasaki Y: Effects of captopril on heavy proteinuria in azotemic diabetes. N Eng J Med 313: 1617-1620, 1985
25. Zimmerman BG: Adrenergic facilitation by angiotesin: Does it serve a physiological function? Clin Sci 60: 343-348, 1981
26. Timmermans PB, Wong PC, Chin AT, Herblin WF, Benfield P, Carini DL, Lee RJ, Wexler RR, Saye JM, Smith RD: Angiotensin II receptors and angiotensin II receptor antagonists. Pharm Rev 45: 205-251, 1993
27. Hansen SK: Renal hypertrophy in experimental diabetes. Kidney Int 23: 643-646, 1983
28. Cortes P, Dumler F, Venkatachalam KK, Levin NW: Effects of diabetes mellitus on renal metabolism. Minor Electrolyte Metab 9: 306-316, 1983
29. 3H-thymidine uptake in diabetic and uninephrectomized rats. Diabetalogia 25: 280-287, 1983
30. Mazzocchi G, Malendowicz LK, Gottardo G, Rebuffat P, Nussdorfer GG.: Angiotensin II stimulates DNA synthesis in rat adrenal zona glomerulosa cells: Receptor subtypes involved and possible signal transduction mechanism. End Res 23: 191-203, 1983
31. 1 receptor inhibits angiotensin II stimulated DNA and protein synthesis in primary cultures of human proximal tubular cells. Kidney Int 52: 699-705, 1997
32. Burnier M, Waeber B, Brunner HR: Clinical pharmacology of the angiotensin II receptor antagonist losartan potassium in healthy subjects. J Hypertens 31(suppl): S23-S28, 1995
33. Wald H, Scherzer P, Popovtzer MM: Na, K-ATPase in isolated nephron segments in rats with experimental heart failure. Circ Res 68: 1051-1058, 1991
34. Brenner BM, Schor N, Ichikawa I: Role of angiotensin-II in the physiologic regulation of glomerular filtration. Am J Cardiol 49: 1430-1433, 1982
35. Lafayette RA, Mayer G, Park SK, Mayer TW: Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. J Clin Invest 90: 766-771, 1992
36. William FK, Sharon A, Mattias A, Dick DZ, Robertm GN, Gail P: Angiotensin converting enzyme inhibitors and progressive renal insufficiency. Ann Int Med 111: 503-516, 1989